SO

Sofinnova Partners — Seed & Series A VC Firm ($500K–$15.0M Checks)

VC
Paris, France (US office: San Francisco, CA)Profile updated November 2026Website

Sofinnova Partners is a Seed, Series A venture capital firm based in Paris, France (US office: San Francisco, CA) investing in Healthcare. The firm typically writes $500K–$15.0M checks and has 280 portfolio companies in our records.

Check size
$500K–$15.0M
Portfolio
280 companies on record
Partners
11 listed
AUM
$4.4B
Stage
Seed, Series A
Sectors
Healthcare
HQ
Paris, France (US office: San Francisco, CA)

Last verified: 2026-07-18

How to approach: warm intro preferred
Stage

Seed, Series A

Check Size

$500K – $15.0M

AUM

$4.4B

Portfolio

280+ companies

Team

11 partners

About Sofinnova Partners

Sofinnova Partners is a venture capital firm headquartered in Paris, France, with a US office in San Francisco, California. The firm invests in early-stage companies focused on therapeutic innovation, particularly in biotech and immuno-oncology.

Sofinnova Partners participates in seed and series A financings. The firm typically deploys between $500K and $15.0M per investment. With $4.4B in assets under management, Sofinnova Partners maintains a focus on the healthcare and oncology sectors. Warm introductions are preferred when approaching the firm.

Investment Thesis

Sofinnova invests in early-stage companies in therapeutic innovation, particularly biotech and immuno-oncology.

How Sofinnova Partners invests

Sofinnova Partners is a vc firm based in Paris, France (US office: San Francisco, CA). The firm invests at the Seed, Series A stages, with a focus on Healthcare.

Sofinnova Partners typically writes checks of $500K–$15.0M per investment, backed by approximately $4.4B in assets under management.

Sofinnova Partners has backed 280 companies in our records, including Corvidia Therapeutics, Orchard Therapeutics, Advanced Perfusion Diagnostics.

Partners & Team

BL

Bommy Lee

Director of Communications

PP

Paola Pozzi

Partner

PP

Paola Pizzi

Director of Operations

JA

Joe Anderson

Partner

GB

Guillaume Baxter

Partner

MC

Matthieu Coutet

Partner

KN

Karl Naegler

Partner

EK

Edward Kliphuis

Partner

GS

Graziano Seghezzi

Managing Partner

AP

Antoine Papiernik

Managing Partner

Biotech
Oncology
Cell Therapy
HR

Henrijette Richter

Managing Partner

Industry Focus

Invests In

Healthcare

Recent Activity

Investment Track Record

Sofinnova Partners has recorded investments in 282 portfolio companies. The firm has backed a range of therapeutic innovation companies including AAVantgarde Bio, ABIONYX Pharma, Abivax, Ablynx NV, Actithera, Addex Therapeutics, Advanced Perfusion Diagnostics, Afyren, Alia Therapeutics, Amolyt Pharma, Artios Pharma, Arzeda, Ascendis Pharma, Asceneuron, and Avantium.

These recorded investments reflect the firm's stated thesis of supporting early-stage companies in healthcare and oncology through seed and series A stages.

Portfolio Companies (280)

Other

CO

Corvidia Therapeutics

Immunotherapy
OR

Orchard Therapeutics

Gene Therapy
AD

Advanced Perfusion Diagnostics

AA

AAVantgarde Bio

AB

ABIONYX Pharma

AB

Abivax

AB

Ablynx NV

AC

Actithera

AD

Addex Therapeutics

AF

Afyren

How to pitch Sofinnova Partners
  • •Raising at Seed, Series A? You're squarely in their sweet spot.
  • •Lead with your fit in Healthcare — the sectors they actively back.
  • •Size your ask to their typical $500K – $15.0M check.
  • •warm intro preferred
  • •Address your outreach to a specific partner, such as Bommy Lee, Director of Communications.
  • •A warm introduction beats a cold email. Get matched and request an intro.

Featured In

Browse More Investors

Fundraising resources

Frequently Asked Questions

See if Sofinnova Partners is a match for your startup

Upload your pitch deck to see how well you match with Sofinnova Partners and 10,000+ other investors.

Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT

Is this your profile? Request a correction or removal